Acea Biosciences, Inc.
Records under this name other than the patents Acea Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to Acea Biosciences, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US D684,703 | Set of Inserts for Co-Culture of Cells in Microtiter Plates now held by Roche Diagnostics Operations, Inc. In force · High confidence | In force | High confidence | |
| US 8,263,375 | Dynamic Monitoring of Activation of G-Protein Coupled Receptor (GPCR) and Receptor Tyrosine Kinase (RTK) in Living Cells Using Real-Time Microelectronic Cell Sensing Technology now held by Agilent Technologies, Inc. In force · High confidence | In force | High confidence | |
| US 10,012,636 | Label-Free Monitoring of Excitation-Contraction Coupling and Excitable Cells Using Impedance Based Systems with Millisecond Time Resolution now held by Agilent Technologies, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 10,533,985 | Label-Free Monitoring of Excitation-Contraction Coupling and Excitable Cells Using Impedance Based Systems with Millisecond Time Resolution now held by Agilent Technologies, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 11,360,072 | Label-Free Monitoring of Excitation-Contraction Coupling and Excitable Cells Using Impedance Based Systems with Millisecond Time Resolution now held by Agilent Technologies, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 8,041,515 | Use of Impedance-Based Cytological Profiling to Classify Cellular Response Profiles Upon Exposure to Biologically Active Agents now held by Agilent Technologies, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 8,252,822 | Heterocyclic Compounds and Uses as Anticancer Agents now held by Acea Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 9,612,234 | Data Analysis of Impedance-Based Cardiomyocyte-Beating Signals as Detected on Real-Time Cell Analysis (RTCA) Cardio Instruments now held by Agilent Technologies, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 9,709,548 | Label-Free Monitoring of Excitation-Contraction Coupling and Excitable Cells Using Impedance Based Systems with Millisecond Time Resolution now held by Agilent Technologies, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 9,200,246 | Co-Culture Device Assembly now held by Agilent Technologies, Inc. In force · High confidence | In force | High confidence |